无码中文字幕一Av王,91亚洲精品无码,日韩人妻有码精品专区,911亚洲精选国产青草衣衣衣

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Opinion

Four questions the US must answer concerning COVID-19

Global Times | Updated: 2020-05-01 17:44
Share
Share - WeChat
[Photo/Agencies]

Fourth, is there a risk of leakage from US biological bases overseas?

The US military has many biological laboratories in Southeast Asia and countries including Pakistan, Afghanistan, Kazakhstan, Kyrgyzstan, Uzbekistan and Georgia. In Ukraine, it was reported that there are 16 biological laboratories set up by the US. According to a spokesperson from the Russian Ministry of Foreign Affairs, the US Department of Defense set up biological laboratories with a dual role in a third country on the pretext of combating biochemical terrorism. The possibility cannot be ruled out that it aims to develop or reorganize various dangerous disease pathogens for military purposes and to strengthen its influence in the biochemical sector overseas.

Why has the US built so many biological laboratories in other countries? What's the purpose in locating these laboratories in countries surrounding China and Russia? Do these laboratories meet security standards? Are there hidden dangers of a leak? When can the US respond to the various suspicions concerning its overseas labs?

Only the US government can answer these questions. We need to respect facts, science and life. We call on the US government to clear these doubts in an open, transparent and responsible manner as soon as possible and invite scientists from all over the world to the US to investigate the origin of the novel coronavirus. The truth must be restored, which will help the US fix its reputation crippled by lies.

The author is an observer of international affairs. 

|<< Previous 1 2 3 4   
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US